Figure 5
Figure 5. Kaplan-Meier estimates of the probability of remaining event-free (stroke or reversion to abnormal TCD velocity) in patients receiving continued blood transfusion (n = 41) compared with no continued transfusion (n = 38). Stopping chronic blood transfusion in SCD patients increases the risk of events within 12 months. Adapted from Adams and Brambilla20 with permission.

Kaplan-Meier estimates of the probability of remaining event-free (stroke or reversion to abnormal TCD velocity) in patients receiving continued blood transfusion (n = 41) compared with no continued transfusion (n = 38). Stopping chronic blood transfusion in SCD patients increases the risk of events within 12 months. Adapted from Adams and Brambilla20  with permission.

or Create an Account

Close Modal
Close Modal